SUMATRIPTAN
NDC 45802-619, sumatriptan, spray, from Padagis Israel Pharmaceuticals Ltd.
- Product NDC
- 45802-619
- Status
- Listed
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- SPRAY
- Route
- NASAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213465
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/45802-619 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SUMATRIPTAN5 mg/1
Pharmacologic classes
Serotonin 1b Receptor Agonists [MoA]; Serotonin 1d Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 45802-619-06 | 45802061906 | 6 CONTAINER in 1 CARTON (45802-619-06) / 1 SPRAY in 1 CONTAINER (45802-619-00) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels?ndc=45802-619NADAC price for package 45802061906
GET /v1/drugs/nadac/45802061906
Use it
Look up 45802-619 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/45802-619 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 45802-619. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.